Low-level light therapy for dry eyes
Low-level light therapy (LLLT) is an emerging treatment for dry eye disease that uses gentle, non-invasive light to improve tear quality and reduce irritation. It offers an option for people whose symptoms persist despite drops, warm compresses or other standard treatments.
How does low-level light therapy work?
LLLT uses specific wavelengths of light directed at the eyelids to improve the function of the meibomian glands. These glands produce the oily layer of tears that prevents the eyes from drying out too quickly. When the glands become blocked or inflamed, patients often experience burning, watering, blurred vision and a gritty sensation.
The therapy helps warm and stimulate these glands from the inside, encouraging oil flow and improving tear stability. Unlike laser treatments, the light used is gentle and does not damage the skin or eyes.
The light emitted by LLLT stimulates reactions at a mitochondrial level, activating an anti-inflammatory effect and stimulating tissue repair and regeneration to improve cell health and function in the meibomian glands. It also helps warm the glands, encouraging oil flow. Unlike laser treatments, the light used is gentle and does not damage the skin or eyes.
What happens during the treatment?
Treatment is delivered via a mask which covers the top half of the patient's face. Most sessions last around 15 minutes and are not painful. Some patients describe a mild warmth but no discomfort.
After the session, patients can return to normal activities straightaway. Make-up can usually be worn later the same day. The number of sessions recommended varies, although many treatment plans involve several appointments spaced over a few weeks.
What benefits can patients expect?
LLLT can lead to improved comfort, fewer flare-ups and a reduction in reliance on artificial tears. Many patients notice a gradual improvement as the meibomian glands become less blocked and tear quality improves. Results vary from person to person, but the treatment is particularly helpful for those with meibomian gland dysfunction, a common cause of dry eye disease.
Benefits often develop over weeks rather than immediately. Some patients require maintenance sessions over time to sustain results, especially if their dry eye is chronic.
When is low-level light therapy recommended?
LLLT is considered when dry eye symptoms persist despite first-line treatments or when meibomian gland dysfunction is confirmed during an eye examination. It can also be helpful for patients who struggle with warm compresses or find them ineffective. LLLT may be combined with other treatments such as intense pulsed (IPL) therapy and/or meibomian gland probing.
Are there any risks or side effects?
LLLT is generally very safe. Temporary skin warmth or mild redness around the eyelids may occur but usually settles quickly. The procedure is non-invasive and does not involve direct contact with the eye itself.
Is low-level light therapy right for you?
Patients who live with persistent dry eye symptoms and meibomian gland dysfunction often find LLLT a helpful addition to their treatment plan. An eye specialist can assess gland health, discuss suitability and recommend the most effective combination of therapies for long-term relief.